Create
Query
event_store.db
—
signals
actions
approvals
artifacts
commitments
constraints
conversation_compaction
conversation_state
conversation_turns
dead_letters
decisions
deliveries
effects
email_messages
email_reply_drafts
email_threads
entities
entity_aliases
entity_tags
episode_context_index
episodes
event_subjects
events
events_archive
fact_sources
facts
inbox_items
inbox_links
jobs
leader_leases
links
memory_candidates
memory_embeddings
memory_items
memory_items_fts
(v)
memory_items_fts_config
memory_items_fts_data
memory_items_fts_idx
opportunity_memory
pending_interactions
proposal_sources
proposals
reminders
schedules
schema_migrations
signal_candidates
signal_fps
signals
sms_conversations
sms_messages
sms_reply_drafts
source_cursors
sources
sqlite_sequence
sqlite_stat1
stream_cursors
threads
watchers
Toggle helper tables
memory_items_fts_content
memory_items_fts_docsize
memory_items_fts_segdir
memory_items_fts_segments
memory_items_fts_stat
Structure
Content
Query
Insert
Drop
Import
Export
Update row sig_9b2b1879e65c in signals
id
sig_9b2b1879e65c
Primary key.
TEXT
event_id
7214
TEXT NOT NULL
watcher_id
NULL
TEXT
signal_type
discovery_sec_filing_delta
TEXT NOT NULL
value
{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1601830/0001712276-26-000003.txt","as_of":"2026-04-09T03:12:49.786272+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1601830/0001712276-26-000003.txt","company":"RECURSION PHARMACEUTICALS, INC.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1601830/0001712276-26-000003.txt","article_chars":1689,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_f9dc4afc12b872be","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1601830/0001712276-26-000003.txt","content_type":"text/plain","enriched_at":"2026-04-09T19:13:33.149769+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1601830/0001712276-26-000003.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1601830/0001712276-26-000003.txt","source_event_id":"evt_93d5e45ebb48","source_quality":"medium","status_code":200,"version":"signal_enrichment_v2"},"form_type":"4","fp":"61319dea6a1beea7","kind":"sec_filing","published_at":"20260408","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.72,"dates_mentioned":["2026-04-08","2026-04-06","2014-03-05"],"entities":[{"asset_class":"equity","name":"Recursion Pharmaceuticals, Inc.","relevance":"high","symbol":"RXRX","type":"issuer"},{"asset_class":"person","name":"Taylor Ben R","relevance":"high","symbol":"","type":"reporting_owner"},{"asset_class":"person","name":"Jonathan Golightly","relevance":"medium","symbol":"","type":"signatory"}],"event_type":"listing","information_gaps":["The cleaned text does not explicitly state the number of shares acquired/sold or the transaction type (e.g., purchase, sale, vesting) beyond the tax-withholding/net settlement footnote.","No prior known state is provided in the signal, so the specific 'delta' versus prior disclosures cannot be determined from the provided text alone.","The exact transaction details (e.g., price, number of RSUs/shares involved) are not present in the provided excerpt."],"key_facts":["SEC accession number: 0001712276-26-000003.","Conformed submission type: 4 (Form 4).","Conformed period of report: 20260406.","Filed as of date: 20260408.","Reporting owner: Taylor Ben R.","Reporting owner position/title shown: Chief Financial Officer.","Issuer: Recursion Pharmaceuticals, Inc. (RXRX).","The filing includes a footnote stating: shares were withheld by the issuer to satisfy tax withholding and remittance obligations in connection with net settlement of restricted stock units.","Signature line includes: /s/Jonathan Golightly, attorney-in-fact.","Class of securities shown: Class A Common Stock."],"numeric_claims":[{"label":"Form filing date (as of)","value":"2026-04-08"},{"label":"Reporting/period date","value":"2026-04-06"}],"primary_claim":"Form 4 for RECURSION PHARMACEUTICALS, INC. was filed on 2026-04-08 (period/reporting date 2026-04-06) by reporting owner Taylor Ben R, CFO.","relevance_score":0.55,"sentiment":"neutral","source_quality":"medium","summary":"Recursion Pharmaceuticals, Inc. (RXRX) filed a Form 4 on 2026-04-08 covering a transaction dated 2026-04-06 by reporting owner Taylor Ben R (Chief Financial Officer). The filing includes a note that some shares were withheld for tax remittance in connection with net settlement of restricted stock units.","topics":["SEC Form 4","insider transaction disclosure","restricted stock units","tax withholding","net settlement"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 4 \u00b7 RECURSION PHARMACEUTICALS, INC. \u00b7 Filed 20260408","ticker":"RXRX","tickers":["RXRX"],"title":"RXRX filed 4","url":"https://www.sec.gov/Archives/edgar/data/1601830/0001712276-26-000003.txt"}
TEXT NOT NULL
threshold
NULL
TEXT
direction
NULL
TEXT
severity
NULL
TEXT
window
NULL
TEXT
source
discovery_sec_filings
TEXT NOT NULL
reason_trace
{"_evidence_event_ids":["evt_93d5e45ebb48"]}
TEXT
dedupe_key
signal_enriched:discovery_sec_filing_delta:2b8ed262d9e479e0
TEXT NOT NULL
throttle_s
INTEGER (default 0
created_at
2026-04-09T03:12:49.786272+00:00
TEXT NOT NULL (default strftime('%Y-%m-%dT%H:%M:%fZ','now')
Update
Cancel